JUNE 18–19, 2019 | 1:00-3:30 pm ET | These interactive training webinars by the Centers for Medicare & Medicaid Services are stand-alone events covering Medicare Program basics. You aren’t required to attend both days, and space is limited.


When it comes to optimal bone health and fracture prevention, there is scant evidence for recommending supplementation with vitamins and minerals other than calcium and vitamin D, according to AACE member Daniel L. Hurley, MD, FACE, who spoke at the AACE 28th Annual Scientific & Clinical Congress.


This year, at the 28th Annual Scientific & Clinical Congress, AACE made changes to the traditional lecture format and pushed for casual presentations, allowing more in-depth and interactive conversations. Read about the change from a member's perspective in this editorial by Archana Sadhu, MD, FACE, longtime Los Angeles resident.


Findings presented at the AACE 28th Annual Scientific & Clinical Congress showed that seeking hospital care for diabetic ketoacidosis during the weekend as opposed to during the week may increase mortality risk.


The Centers for Medicare and Medicaid Services (CMS) has posted the following new resources to the Quality Payment Program (QPP) Resource Library, including the 2019 MIPS Eligibility Decision Tree, specialty guides, and eligibility redetermination fact sheet.


The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (RFI) seeking new ideas from the public on how to continue the progress of the Patients over Paperwork initiative. Since launching in fall 2017, Patients over Paperwork has streamlined regulations to significantly cut the “red tape” that weighs down our healthcare system and takes clinicians away from their primary mission—caring for patients. 


The Quality Payment Program (QPP) is creating more ways for developers to build software that integrates directly with CMS applications and data. As part of that initiative, the Quality Payment Program Developer Tools now includes information on how to programmatically interact with eligibility data via the Eligibility Application Programming Interface (API).


Type 2 diabetes (T2D) is associated with increased risk for fractures in the short term but not in the long term, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Treatment with linagliptin in patients with type 2 diabetes (T2D) and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events or hospitalization for heart failure, according to results of the CARMELINA study (Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus) presented at the AACE 28th Annual Scientific & Clinic


Abaloparatide followed by alendronate treatment may improve bone mineral density (BMD) in women with postmenopausal osteoporosis and type 2 diabetes (T2D), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


The use of an insulin pump to deliver continuous pulsatile cortisol may be a viable treatment option in patients with severe adrenal insufficiency who are unresponsive to oral corticosteroids, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Biochemical markers and clinical signs and symptoms of endogenous Cushing syndrome improved after 6 months of levoketoconazole therapy, according to phase 3 study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Significantly more euthyroid patients with thyroid disease suffer from anxiety compared with depression, regardless of whether they have Hashimoto thyroiditis autoimmunity, according to research results presented at the AACE 28th Annual Scientific & Clinical Congress. 


A weighted cardiometabolic disease staging risk score can be used to quantify race- and sex-specific type 2 diabetes risk in a large, diverse population, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress. 


Hypothyroidism is a risk factor for increased length of hospital stay and mortality in patients with congestive heart failure (CHF), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Teprotumumab effectively reduces proptosis in patients with active thyroid eye disease, according to phase 3 confirmatory trial data presented at the AACE 28th Annual Scientific & Clinical Congress.


For indeterminate thyroid nodules following fine needle aspiration, evidence of thick post-microcystic reflection on ultrasound was found to be associated with malignant nodules, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


Lower income and education levels may negatively affect the experience and expectations of patients who are obese who receive care for weight management, according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.


The cardiovascular and renal effects of treatment with canagliflozin in patients with type 2 diabetes are more prominent in patients not taking metformin compared with patients treated with canagliflozin as an add-on to metformin, according to data from the CANVAS (CANagliflozin cardioVascular Assessment Study) Program presented at the AACE 28th Annual Scientific & Clinical Congress.


Endocrine Today has compiled a list of the top five news stories posted from the American Association of Clinical Endocrinologists Scientific & Clinical Congress, held April 24-28, 2019, in Los Angeles.


Distinctive serum steroid profiles might emerge in patients with adrenal tumors and Cushing's syndrome, according to research reported by Shobana Athimulam, MBBS, of the Mayo Clinic in Rochester, Minnesota, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The ThyroSeq v3 Genomic Classifier was able to effectively classify thyroid nodules with samples collected through fine needle aspiration (FNA), according to research reported by Lindsey Tolino, MBA, of the University of Pittsburgh Medical Center in Pennsylvania, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The investigational agent teprotumumab was effective for reducing proptosis associated with thyroid eye disease, according to late-breaking phase III data presented by Raymond Douglas, MD, PhD, of Cedars Sinai Medical Center in Los Angeles, and colleagues, at the AACE 28th Annual Scientific & Clinical Congress.


The investigational agent relacorilant significantly improved excess cortisol in patients with endogenous hypercortisolism, researchers reported at the AACE 28th Annual Scientific & Clinical Congress.


Among patients on hemodialysis, trabecular bone score was helpful in predicting fracture risk, researchers reported during an oral presentation of the findings at AACE’s 28th Annual Scientific & Clinical Congress.


AACE Member Roy Taylor, MD, discussed the pathogenesis of hepatic insulin resistance in people with type 2 diabetes in an interview at AACE’s 28th Annual Scientific & Clinical Congress.


AACE Member Felicia Cosman, MD, professor of medicine at Columbia University, New York, discussed the current state of osteoporosis treatment in an interview at AACE’s 28th Annual Scientific & Clinical Congress.


Lewis E. Braverman, MD, MACE, 89, passed away peacefully on Monday, June 10, 2019. He leaves his wife Mimi Braverman; his sons, William Braverman and Daniel Braverman; and his five grandchildren.


CR 11003 introduced the enrollment process for the providers who intend to get their Additional Documentation Request (ADR) letters electronically (as eMDR) through their registered Health Information Handler. Make sure your billing staffs are aware of these changes.


The AACE/ACE My Diabetes Emergency Plan program helps people with diabetes prepare for emergency situations or natural disasters that could disrupt daily routines and limit access to needed diabetes medications and supplies.
With the 2019 Hurricane Season officially underway, it's particularly urgent that people with diabetes have a plan and evacuation kits ready.


Kevin Pho, MD, is a board-certified internal medicine physician and founder of KevinMD, social media’s leading physician voice. He has been named the web’s top social media influencer in health care and medicine. Dr. Pho is coming to AACE to deliver the keynote address “Social Media and the Physician” on Saturday, April 27. AACE2019News.com recently had the opportunity to ask Dr. Pho a few questions about his presentation, social media and why endocrinologists should get on the social media train.


Bhatt DL, Steg G, Miller M, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380:11-22.

https://www.nejm.org/doi/full/10.1056/NEJMoa1812792


Treatment of hypercholesterolemia with statins results in significant reductions in cardiovascular risk; however, individuals with well-controlled low-density lipoprotein cholesterol (LDL-C) levels, but persistent high triglycerides (TG), remain at increased risk.


Shin J, Chung JW, Jang HS et al. Achieved low-density lipoprotein cholesterol level and stroke risk: A meta-analysis of 23 randomised trials. Eur J Prev Cardiol 2019:2047487319830503.

http://www.ncbi.nlm.nih.gov/pubmed/?term=30782002


Fogacci F, Banach M, Mikhailidis DP et al. Safety of Red Yeast Rice Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pharmacol Res. 2019; 143:1-16.

http://www.ncbi.nlm.nih.gov/pubmed/?term=30844537


Ference BA, Ray KK, Catapano AL, et al. Mendelian Randomization Study of ACLY and Cardiovascular Disease.


Ray KK, Bays HE, Catapano AL, et al. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol. N Engl J Med. 2019;380:1022-1032.

https://www.nejm.org/doi/full/10.1056/NEJMoa1803917


An estimated 30.3 million Americans have type 2 diabetes (T2D), a complex, progressive disease that requires intensified treatment over time.1-3 The complexity of T2D management, coupled with the need to tailor treatment recommendations to individual patients, presents an ongoing clinical challenge. The number and variety of treatment options available for T2D has increased dramatically in the last 15 years, with several new drug classes emerging as safe and effective.2,4,5


A preliminary slate of candidates for the election of Officer positions for a one-year (1) term, five (5) open positions on the Board of Directors for election to a three-year (3) term (2019-2022) and one (1) open position on the Board of Directors for a one-year (1) term (2019-2020) to fill the unexpired term of Dr. Sethu Reddy, who was elected Secretary in 2018, was sent to the membership via email/fax on December 28.


Horizon Reimbursement Policies effective February 25, 2019 will be applied to professional claims for services provided to patients enrolled in fully insured groups and ASO groups that opted in to policy guidelines. Diabetic screening services, duplicate claim logic for independent lab services, lab services billed by physicians are just a few of the policies that may affect endocrinologists. We strongly encourage you to review the content of each policy.

2019 Training Materials for Part D Opioid Policies.